Readings

Textbooks

Required : Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes . Oxford University Press. 2005 

Optional (Higher Level) : Gold MR, Siegel JE, Russell LB, Weinstein MC (eds.). Cost-Effectiveness in Health and Medicine. Oxford University Press. 1996.  

Optional (Lower Level) : Haddix AC, Teutsch SM, Corso PS. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation . Oxford University Press. 2002.

SESSION #	TOPIC	READINGS
1	Introduction to Cost-Outcome Studies	Drummond Chapters 1 & 2 Mauskopf JA, Paul JE, Grant DM, Stergachis A. The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics. 1998;13:277-88.
2	Economics and Economic Evaluation	Kenkel D. On valuing morbidity, cost-effectiveness analysis, and being rude. J Health Econ. 1997;16:749-57.
3	Study Designs	Drummond Chapters 5 (skip 5.5 and 5.6), 8, and 9
4	Types of Cost Data	Drummond Chapter 4 Ross TK. Analyzing health care operations using ABC. J Health Care Finance. 2004;30:1-20.
5	Discounting, Inflation, Capital Costs	Walker D, Kumaranayake L. Allowing for differential timing in cost analyses: discounting and annualization. Health Policy Plan. 2002;17:112-8.
6	Productivity Cost Concepts	Koopmanschap M, Burdorf A, Jacob K, Meerding WJ, Brouwer W, Severens H. Measuring productivity changes in economic evaluation: setting the research agenda. Pharmacoeconomics. 2005;23:47-54.
7	Contingent Market Valuation	Drummond Chapter 7 Smith RD. Construction of the contingent valuation market in health care: a critical assessment. Health Econ. 2003;12:609-28.
8	What is a QALY or DALY?	Drummond Chapter 6 Determinants of health economic decisions in actual practice: the role of behavioral economics. Value Health. 2006;9:65-7. Reidpath DD, Allotey PA, Kouame A, Cummins RA. Measuring health in a vacuum: examining the disability weight of the DALY. Health Policy Plan. 2003;18:351-6.
9	Preference Elicitation Methods	Nickerson CA . Assessing convergent validity of health-state utilities obtained using different scaling methods. Med Decis Making. 1999;19:487-98.
10	Multiattribute Utility Theory & Instruments	Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making. 2006;26:391-400.
11	Decision Rules	Drummond Chapters 5.5 & 5.6 Dowie J. Why cost-effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant. Health Econ. 2004;13:453-9.
12	Sensitivity Analysis and Inference	Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res. 2006;6:52. Yokota F, Thompson KM. Value of information analysis in environmental health risk management decisions: past, present, and future. Risk Anal. 2004 Jun;24:635-50.
13	Reference Case & Global Recommendations	Drummond Chapter 3 Phillips KA, Chen JL. Impact of the U.S. panel on cost-effectiveness in health and medicine. Am J Prev Med. 2002;22:98-105.